Synergy between CD8 T Cells and Th1 or Th2 Polarised CD4 T Cells for Adoptive Immunotherapy of Brain Tumours

• Sabine Hoepner,

  Current address: Tumor Immunology, Department of Clinical Research, University of Bern, Bern, Switzerland

  Affiliation Centre of Oncology, Geneva University Hospitals and University of Geneva, Geneva, Switzerland

  ⨯
• Jacelyn M. S. Loh,

  Current address: Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand

  Affiliation Centre of Oncology, Geneva University Hospitals and University of Geneva, Geneva, Switzerland

  ⨯
• Cristina Riccadonna,

  Affiliation Centre of Oncology, Geneva University Hospitals and University of Geneva, Geneva, Switzerland

  ⨯
• Madiha Derouazi,

  Affiliation Centre of Oncology, Geneva University Hospitals and University of Geneva, Geneva, Switzerland

  ⨯
• Céline Yacoub Maroun,

  Affiliation Centre of Oncology, Geneva University Hospitals and University of Geneva, Geneva, Switzerland

  ⨯
• Pierre-Yves Dietrich,

  Affiliation Centre of Oncology, Geneva University Hospitals and University of Geneva, Geneva, Switzerland

  ⨯
• Paul R. Walker

  * E-mail: paul.walker@hcuge.ch

  Affiliation Centre of Oncology, Geneva University Hospitals and University of Geneva, Geneva, Switzerland

  ⨯